No 1299 Umuhanda wa Heze, Akarere ka Huaiyin, Umujyi wa Jinan, Intara ya Shandong, Ubushinwa
baofayu@baofacancer.com
1
Kinyarwanda
Komeza

Komeza

Komeza

20241205093268316831

Baofa Yu, Umuganga mukuru wa M.D mu Bushinwa, Porofeseri Adjunct muri kaminuza ya Texas (El Paso) (2016) na Porofeseri Adjunct muri kaminuza y’ubuzima y’uburengerazuba (2016). Yarangije mu Ishuri Rikuru ry’Ubuvuzi rya Peking Union (Peking Union Medical College) mu 1988. Yabaye impamyabumenyi y'ikirenga muri dogiteri muri UCSD kuva 1990 kugeza 1991, Salk kuva mu 1992 kugeza 1993, Assistant Adjunct Professor, UCSD kuva 1994 kugeza 1998. Muri Amerika, yakoraga cyane cyane mu bushakashatsi bwakozwe ku gutanga ibiyobyabwenge bya kanseri no gutanga ibinyabuzima bya kanseri. Yahimbye igitekerezo gishya cyo gukoresha ibibyimba nka sisitemu ihoraho yo kurekura imiti igabanya ubukana hamwe nuburyo bwo kuvura ikigega kirekura kirambye, gifite agaciro k’amavuriro, cyitwa kandi ultro-Minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC). Mu 1998, yasubiye mu Bushinwa maze ashinga ikigo cy’ubushakashatsi cya Shandong Baofa n’ibitaro bya kanseri bya Taimei Baofa mu cyaro cya Dongping ashora imari mu ikoranabuhanga, maze aba umuyobozi w’ishami rishinzwe kuvura kanseri ya Shandong Baofa, LTD., Nyuma ashinga ibitaro bya kanseri ya Jinan Baofa (2004). Ibitaro Bikuru bya Dongping Baofa (2011), Ibitaro bya Kanseri ya Baofa (2013) na Immuno Oncology Systems, Inc. Uyu munsi, ubu buvuzi bwemewe "Amabwiriza y’ubuvuzi agamije kuvura indwara ya kanseri yateye imbere" (Ikigeragezo) (ku nshuro ya 7), yateguwe n’ishyirahamwe ry’abashinwa barwanya kanseri, Ikigo cy’igihugu gishinzwe ubushakashatsi ku buvuzi bw’ubuvuzi bwa Radiologiya n’ubuvuzi, hamwe n’igihugu gishinzwe ubuvuzi bushya bw’ubuvuzi, Ikinyamakuru cya Clinical Radiology, umuzingo wa 43, nimero 19-16, 2024.

Yasohoye impapuro zirenga 60 zerekeye ubu buvuzi muri Kamere: Raporo y’ubumenyi, Ikinyamakuru cya Kanseri, J Basic Clin Pharma, J Immunological Sci, Ikinyamakuru cy’Ubuyapani cya Gastroenterology na Hepatology, Uburyo bushya bw’ubushakashatsi mu Kwiga Kanseri, Ikinyamakuru cyitwa Academic Journal of Engineering Studies, Nov Res Sci, Ikinyamakuru cya Hepatocellular carcinoma, Kanseri y'ibihaha, Ubuvuzi, Ubushakashatsi, Isanduku, Proc.Natl.Acad.Sci.USA, Pancreas nibindi binyamakuru hamwe nimpapuro nyinshi ziposita bitabiriye inama ya AACR na ASCO.

Umusanzu wacu nyamukuru nuko ubuvuzi burambye-burekura buhuza ibyiza bya chimiotherapie na immunotherapie, kandi kunshuro yambere, byombi byahujwe kandi bikoreshwa mubuvuzi bwa intratumoral binyuze mubutabazi. Ihuza ubuvuzi bw’ibanze ndetse n’isi yose, kandi ikongerera igihe n’ibikorwa by’ibiyobyabwenge binyuze mu kurekura burundu ibiyobyabwenge mu kibyimba, bidakina gusa ingaruka za anticancer y’imiti y’imiti ya chimiotherapie, ahubwo binita ku ruhare rw’imiti ikingira indwara, bityo bikuzuza ibitagenda neza mu bundi buryo bwo kuvura, bitanga ibitekerezo bishya n’uburyo bwo kuvura kanseri, cyane cyane mu kugabanya ibibyimba byo hagati no gutera imbere cyane cyane; Ubuvuzi bwa UMPIC bufite inyungu zo gukoresha ikibyimba nkisoko ya antigen hamwe ninkingo ya autologique, nayo ijyanye niterambere ryubuvuzi bwihariye. Kandi ikoreshwa ku ivuriro, hapten ihujwe n’imiti ya chimiotherapie kugirango irekure irekure ivura kanseri yandura yibanze, mugihe itera ingaruka zidasanzwe, icyingenzi kikaba ari ugutera ubudahangarwa bw'umubiri, CD4, CD8, DC, T na NK, hamwe na B-selile yibibyimba autoantibodies: Antibodies to P53, P16, Cmyc, Zeta, IMPv1 ni ubwambere dusanze T na B bafite uruhare mukurwanya ubudahangarwa bw'umubiri, hamwe nibikorwa byubuvuzi byingaruka za kure hamwe nubu buvuzi bwatoranijwe kugirango "Amabwiriza yubuvuzi bwo kuvura indwara ziterwa na kanseri yanduye" (Ikigeragezo) (ku nshuro ya 7) yateguwe n’ishyirahamwe ry’abashinwa barwanya kanseri, Ikigo cy’igihugu gishinzwe ubuvuzi bw’ubuvuzi cya Radiology na Therapy. 43, nimero 19, 2024, 1636-1648.

Reba:

Umwaka Ingingo Umutwe Itangazwa
2015 Hapten-yongerewe imbaraga zo kuvura mugihe cyambere cya kanseri yibihaha na ultra-minimum incision personal intratumoral Kanseri y'ibihaha: Intego no kuvura, 2015; 6 1-11
2015 Kurinda ibisanzwe kugirango turusheho kwica kanseri 2015 Abanditsi. Ubuvuzi bwa Kanseri bwanditswe na John Wiley & Sons Ltd.1349-1403
2015 Intege nke ninzitizi zo gukoresha imbeba nimbeba mubushakashatsi bwa Kanseri ya Chimoprevention Ikinyamakuru cya Kanseri 2015; 6 (10): 1058-1065.doi: 10.7150 / jca.12519
2015 Hapten-yongerewe imbaraga muri rusange igihe cyo kubaho muri kanseri ya hepatocellular yateye imbere na ultra-minimum incision personal intratumoral chemoimmunotherapy Ikinyamakuru cya Hepatocellular Carcinoma ， 2015: 2，1-12
2015 Gukoresha hapten ikomatanyije imiti ya Catatonic mugutezimbere ingaruka zo kuvura murwego rwo hejuru rwa kanseri yandura Ikinyamakuru cyubushakashatsi bwumwijima, Imivurungano & Ubuvuzi, 2015,1 (3): 013-23
2016 Kwiga ku kamaro ko gukumira ihindagurika rya kanseri ikira na Tumour Benign Ikinyamakuru cya Kanseri 2016; 7 (4): 436-445. doi: 10.7150 / jca.13832
2016 Hapten Yatezimbere Muri rusange Inyungu Zo Kurokoka Mubyiciro Byanyuma bya Kanseri Yibihaha Atari Ntoya (NSCLC) na Ultra-Minimum Incision Yumuntu Wihariye Imiti ya Chemo Immunotherapy (UMIPIC) Ubuvuzi hamwe na hamwe nubuvuzi bwimirasire Tanga intoki Ikinyamakuru cyo Kurinda Kanseri & Ubushakashatsi Bugezweho 2016, 4 (2): 00116
2020 Uburyo bushya bwa Eclectic Uburyo bwo kuvura Kanseri hamwe na Liquid Knife & Immuno Therapy: UMIPIC, irashobora Kurenga Kubaga, Kubaga Chimoterapi no Kuvura Imirasire kuri Stage zose za Tumor Solid Uburyo bushya muburyo bwo Kwiga Kanseri NACS.000590. 4 (3) .2020
2020 Ibiyobyabwenge Bivanze na H2O2 Gutera Intratumoral kugirango uhindure Matrix idasanzwe muri Coagulum ya Autologique nka Depot yibiyobyabwenge Ubushakashatsi bushya mubumenyi NRS.000584. 4 (2) .2020
2020 Ibyiringiro bishya byo kuvura kanseri hamwe na Liquid Knife & Immuno Therapy: UMIPIC Ibigezweho muri Clinical & Medical Science ISSN: 2689-4246 Itangazwa: Tariki ya 20 Werurwe 2020
2022 Indwara ikaze ya Tumor hamwe na CD4 / 8 + na CD11 + Yongerewe igihe kirekire cyo Kurokoka Mubyiciro Byambere Byibibyimba Byose Byakomeye na Ultra Minimum Incision Yihariye Yumuntu Chemoimmunotehrapy Ikinyamakuru cyo mu Buyapani cya Gastroenterology na Hepatology
2022 Gutwika gukabije hamwe no kwerekana bidasanzwe CD11 & CD4 Bitanga Ingaruka ya Abscopal na Injection Injection Imiti ya Chimiotherapie Imiti hamwe na Hapten muburyo bw'inyamaswa Ikinyamakuru cyubumenyi bwikingira
2022 Igihe gishya cyo kubaga Immuno kiraje: Uburyo bushya bwa elektiki bwo kuvura kanseri hamwe na Liquid Knife & Immuno Therapy Ikinyamakuru cyigisha amasomo yubuhanga
2022 Indwara ikabije ya Tumor hamwe na CD4 / 8 + na CD11 + Kuramba Ingaruka zo Kurokoka zatewe no gutera inshinge Intratumral Optimum Guhuza imiti ya chimiotherapie hamwe na Hydralazine nkuko bibaye mubyitegererezo by'inyamaswa Ikinyamakuru cyo mu Buyapani cya Gastroenterology na Hepatology
2023 Kangura Uturemangingo twa Immune by Hapten Yongerewe Imiti ya Chimoterapi hamwe na Penicillin Prolong Pancreatic Kanseri Kurokoka Ikinyamakuru cya Kanseri 2023; 14 (8): 1282-1292
2023 Gutsindira neza muburyo bwa antigen ya kirimbuzi ya antigen ikoresheje ibibyimba biterwa na autoantibodies (iTAA） imiterere ya portfolio Raporo yubumenyi umuzingo wa 13, Ingingo nimero: 9902 (2023)
2023 Impinduka z'umubiri zatewe na Intratumoral Hapten Yongeyeho imiti ya chimiotherapie ya EndometrialCancer Ikinyamakuru cya Farumasi Yibanze n’Ubuvuzi Nyakanga 31,2023. DOI: 10.37532 / 0976-0113.14 (S1) .17
2023 Kanseri Immunotherapy Gutegura hamwe na selile Immune Gukora binyuze muri Hapten-Yongerewe Chimiotherapie muri Kanseri Yibanze Yibihaha Ikinyamakuru cya Farumasi Yibanze n’Ubuvuzi Ku ya 11 Kanama 2023. DOI: 10.37532 / 0976-0113.14 (S1) .18
2023 scRNA-Seq Isesengura Immune Impinduka za Intratumoral Hapten Yongeyeho imiti ya chimiotherapie yo kuvura kanseri y'ibere y'abagabo IKINYAMAKURU CYA KANSERI NA TERAPEUTIQUE ZA KININI 27 Ugushyingo 2023. DOI: 10.26502 / jcsct.5079214
2024 Ingaruka za sodium stibogluconate mugushakisha no gukangura ingirangingo z'umubiri mumazi meza ya kanseri yandura kanseri yo gutegura immunotherapy Imipaka muri immunologiya 19 Mutarama 2024. DOI: 10.3389 / fimmu.2023.1315468
2024 Hapten-Mediated Chemical Immune Therapy hamwe nubuyobozi bwibiyobyabwenge muri kanseri yinkondo y'umura idafite Hysterectomy Ikinyamakuru cyo kubaga 13 Kamena 2024. DOI: 10.29011 / 2575-9760.11063
2024 Koresha umwirondoro wa scRNA-Seq kugirango usobanure igisubizo cyikingira nyuma yikibyimba Hapen Yongerewe Chimiotherapie Kubibazo bya Anaplastique Anaplastique Hemangiopericytoma Umwijima Metastasis: Raporo Yurubanza. Ikinyamakuru cyo kubaga 10 Kamena 2024. DOI: 10.29011 / 2575-9760.11063
Subira kuri Prof. Yu
Murugo
Imanza zisanzwe
Ibyerekeye Twebwe
Twandikire

Nyamuneka udusigire ubutumwa